Clinical Scorecard: New Guidance on Chronic Insomnia Treatment
At a Glance
Category
Detail
Condition
Chronic insomnia disorder in adults
Key Mechanisms
Cognitive behavioral therapy for insomnia (CBT-I) and pharmacotherapy, alone or in combination
Target Population
Adults with chronic insomnia
Care Setting
Outpatient clinical settings with access to behavioral and pharmacologic treatments
Key Highlights
CBT-I is the preferred first-line treatment for chronic insomnia.
Combination therapy offers modest benefits over pharmacotherapy alone but no clinically meaningful improvements over CBT-I alone.
Pharmacotherapy alone is appropriate when CBT-I is unavailable, unaffordable, or not feasible.
Guideline-Based Recommendations
Diagnosis
Diagnosis based on clinical evaluation consistent with chronic insomnia disorder criteria.
Management
Use CBT-I as first-line therapy for chronic insomnia.
Consider combination therapy (CBT-I plus pharmacotherapy) over pharmacotherapy alone in selected patients prioritizing rapid symptom relief or short-term total sleep time increases.
Avoid combination therapy over CBT-I alone due to lack of clinically meaningful added benefit.
Reserve pharmacotherapy alone for patients unable to access or engage in CBT-I.
Monitoring & Follow-up
Monitor for adverse effects, particularly morning sleepiness, when using combination therapy.
Assess insomnia severity, sleep continuity, and daytime functioning to guide treatment adjustments.
Risks
Combination therapy is associated with slightly higher rates of adverse effects compared to pharmacotherapy alone.
Medication-related adverse effects should be considered, especially when avoiding pharmacotherapy.
Patient & Prescribing Data
Adults with chronic insomnia, including those prioritizing rapid symptom relief or short-term sleep improvements.
Combination therapy may provide small improvements over medication alone but does not enhance outcomes beyond CBT-I alone; pharmacotherapy alone is suitable when CBT-I is inaccessible.
Clinical Best Practices
Employ shared decision-making incorporating patient preferences, clinical priorities, and access to care.
Tailor treatment strategies individually, considering the conditional nature of recommendations and evidence limitations.
Utilize digital CBT-I and telemedicine to improve access where traditional CBT-I is limited.
Recognize and address disparities in access to behavioral treatments to reduce inequities in insomnia care.
